#pharma-sector
Aurobindo Pharma: Strong dose of growth opportunities
Aurobindo’s near-term growth driven by US/Lannett, Europe, and Pen-G, with long-term upside from biologics/biosimilars and margin-led expansion.
Sensex cracks 700 pts intraday, Nifty below 23,250: 5 factors behind crash
Stock market crash: Most sectoral indices, barring pharma, traded with deep cuts. Banking and financial services stocks were the top drags in trade today.
Buy capital goods on dips, stay cautious on IT and consumption: Sudip Bandyopadhyay
Market expert Sudip Bandyopadhyay outlines investment strategies across key sectors. He sees opportunities in State Bank of India and a generational re-rating for the pharma sector. Capital goods also present long-term buying windows. Consumption requires cau…